Chile’s National Economic Prosecutor (FNE) has said it received a new complaint regarding possible instances of collusion between major drug-store chains, this time affecting the Valdivia region. The complaint, presented by the Movimiento Autónomo Regional de Los Rios (Los Rios Autonomous Regional Movement), has sought to bring attention to this problem, which they claim affects several communal areas.
Miguel Ángel Carrasco, a physician and member of the Los Ríos movement, explained that their suspicions were raised due to the minimal difference in prices found among the most common medications used by Chilean consumers. The group has gathered and presented the FNE with data collected from communal villages in the Valdivia and Union regions, with price comparisons for various brands of medication, including anti-inflammatory and anti-anxiety medication.
Full Content: Bio Bio Chile
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Russian Lawmakers Approve Cryptocurrency Use in International Trade
Jul 30, 2024 by
CPI
UAE Halts US Talks with AI Firm G42 Amid China Tech Concerns
Jul 30, 2024 by
CPI
UK Antitrust Regulator Probes Google’s Ties with AI Firm Anthropic
Jul 30, 2024 by
CPI
Medical and Industry Groups Seek Court Intervention Against FTC Noncompete Ban
Jul 30, 2024 by
CPI
Meta Strikes $1.4 Billion Deal with Texas Over Biometric Data Suit
Jul 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – International Trade & Antitrust
Jul 26, 2024 by
CPI
What is Wrong with the WTO Discipline on Subsidies?
Jul 26, 2024 by
CPI
The Abiding Tension Between Trade Remedy Law and Antitrust
Jul 26, 2024 by
CPI
Trade and Antitrust: An End to Isolationism
Jul 26, 2024 by
CPI
International Trade Law and Domestic Regulation of Generative Artificial Intelligence: Divergent Approaches?
Jul 26, 2024 by
CPI